Jeffrey B. Landau - Dec 20, 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
Chief Business Officer
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Jeffrey B Landau
Stock symbol
CTMX
Transactions as of
Dec 20, 2023
Transactions value $
-$5,628
Form type
4
Date filed
12/22/2023, 04:12 PM
Previous filing
Dec 19, 2023
Next filing
Jan 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$5.63K -4.08K -4.5% $1.38 86.6K Dec 20, 2023 Direct F1, F2
holding CTMX Common Stock 4.5K Dec 20, 2023 Fidelity Traditional IRA
holding CTMX Common Stock 3.18K Dec 20, 2023 Schwab ROTH IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
F2 Includes 52,205 restricted stock units.